Get 40% Off
☕ Buy the dip? After losing 17%, Starbucks sees an estimated 20% upside. See the top Undervalued stocks!Unlock list

IDEX (IEX) Shares Up 31% YTD: What's Driving The Rally?

Published 09/02/2019, 08:16 AM
Updated 07/09/2023, 06:31 AM

Shares of IDEX Corporation (NYSE:IEX) have rallied about 31% so far this year. Also, the company has significantly outperformed its industry’s rise of 20.5% over the same time frame.



The Zacks Rank #3 (Hold) stock, which has a market cap of roughly $12.3 billion, has impressed investors with its recent earnings streak. It surpassed estimates all through in the four trailing quarters, the average positive surprise being 4.14%.

You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Let’s analyze the reasons behind the company’s impressive price performance and find out if there is room for further appreciation:

Growth Drivers

IDEX has been gaining from its solid product portfolio, diligent execution of productivity initiatives and growth investments. Over time, the company has solidified the product portfolio and leveraged business opportunities through acquisition of assets. In this regard, the acquisition of the intellectual property assets of Phantom Controls (in June 2018) has been augmenting the company's water-flow offerings under Akron Brass, Hale Products and other Class 1 Electronics brands. Also, the Finger Lakes Instrumentation buyout (in July 2018) has been solidifying IDEX's Health & Science business. In addition, the company’s buyout of Velcora Holding AB (in July 2019), and its Steridose and Roplan businesses, will help it in enhancing the sealing solutions platform.

Also, IDEX is witnessing robust demand environment across major life science markets. Notably, solid original equipment manufacturers demand along with a favorable chemical market is likely to drive the company’s top-line performance. In addition, strength in Viking and Richter businesses, and strong momentum across fire and safety businesses are likely to boost revenues of the company. For 2019, the company anticipates overall revenues to increase 3-4 % year over year, on an organic basis.

Estimate Revisions

The Zacks Consensus Estimate for 2019 earnings for IDEX has climbed nearly 0.2% over the past 60 days from $5.82 to $5.83. For the year, four estimates have been being revised upward in the past couple of months.

Upbeat Q2 Performance

IDEX reported adjusted earnings per share of $1.50 in second-quarter 2019, marking a 7.1% year-over-year rise. Moreover, the figure beat the Zacks Consensus Estimate by 0.67%. This earnings improvement is primarily attributable to healthy organic growth. The company expects to gain from a diversified business structure, solid product portfolio, execution abilities and growth investments. It predicts adjusted earnings per share of $5.78-$5.85 for 2019, higher than $5.70-$5.85 predicted earlier. For the third quarter, earnings are projected to be $1.45-$1.47, indicating a rise from $1.41 reported in the year-ago quarter.

Notably, IDEX has been able to significantly outperform its peers such as DXP Enterprises, Inc. (NASDAQ:DXPE) , Flowserve Corporation (NYSE:FLS) and Parker-Hannifin Corporation (NYSE:PH) , which have gained 16.6%, 12.2% and 11.1%, respectively, year to date.

The Hottest Tech Mega-Trend of All

Last year, it generated $8 billion in global revenues. By 2020, it's predicted to blast through the roof to $47 billion. Famed investor Mark Cuban says it will produce "the world's first trillionaires," but that should still leave plenty of money for regular investors who make the right trades early.

See Zacks' 3 Best Stocks to Play This Trend >>

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .


Flowserve Corporation (FLS): Free Stock Analysis Report

DXP Enterprises, Inc. (DXPE): Free Stock Analysis Report

IDEX Corporation (IEX): Free Stock Analysis Report

Parker-Hannifin Corporation (PH): Free Stock Analysis Report

Original post

Zacks Investment Research

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.